Zombie Aqua™ Fixable Viability Kit

Pricing & Availability
Other Names
Fixable Dye, Fixable Viability Dye
Ave. Rating
6 reviews
Product Citations
publications
Zombie_Aqua_Viability_Dye_032713
One day old splenocytes were stained with Zombie Aqua™ and analyzed without fixation (blue) or analyzed after fixation and permeabilization (red). Cells alone without Zombie Aqua™ staining are indicated in black.
  • Zombie_Aqua_Viability_Dye_032713
    One day old splenocytes were stained with Zombie Aqua™ and analyzed without fixation (blue) or analyzed after fixation and permeabilization (red). Cells alone without Zombie Aqua™ staining are indicated in black.
  • Zombie_Aqua_Viability_Dye_nowash_050713
    One day old splenocytes were stained with Zombie Aqua™ and analyzed without fixation (blue) or analyzed after fixation and permeabilization (red). Cells alone without Zombie Aqua™ staining are indicated in black.
See Zombie Aqua™ spectral data See high resolution IF data...
Cat # Size Price Quantity Avail. Save
423101 100 tests 75 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
423102 500 tests 285 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Zombie Aqua™ is an amine-reactive fluorescent dye that is non-permeant to live cells but permeant to cells with compromised membranes. Thus, it can be used to assess live vs. dead status of mammalian cells. Zombie Aqua™ is a polar, water-soluble dye providing very bright green fluorescence, making it suitable for use in multi-color detection.
 

Product Details
Technical Data Sheet (pdf)

Product Details

Preparation
Zombie Aqua™ Fixable Viability Kit is composed of lyophilized Zombie Aqua™ dye and anhydrous DMSO. For reconstitution, pre-warm the kit to room temperature; add 100 µl of DMSO to one vial of Zombie Aqua™ dye and mix until fully dissolved. 100 tests = 1 vial of Zombie Aqua™ + DMSO, 500 tests = 5 vials of Zombie Aqua™ + DMSO.
Storage & Handling
Store kit at -20°C upon receipt. Do not open vials until needed. Once the DMSO is added to the Zombie Aqua™ dye, use immediately, or store at -20°C in a dry place and protected from light, preferably in a desiccator or in a container with desiccant for no more than one month. The unopened kit is guaranteed for six months.

This product has a shelf-life of 12 months or less. Please contact our technical support team for lot specific CoA and expiration date inquiries of this product.
Application

FC, ICFC - Quality tested
IF - Validated

Recommended Usage

Each lot of this product is quality control tested by immunofluorescent staining with flow cytometric analysis.

For flow cytometry, the suggested dilution is 1:100-1:1000 for 1-10 million cells. For immunofluorescence microscopy, the suggested dilution is 1:1000. It is recommended that the reagent be titrated for optimal performance for each application, as optimal dosage varies with cell type.

 

Excitation Laser
Violet Laser (405 nm)
Application Notes

Standard Cell Staining Protocol:

  1. Prior to reconstitution, spin down the vial of lyophilized reagent in a microcentrofuge to ensure the reagent is at the bottom of the vial.
  2. For reconstitution, pre-warm the kit to room temperature; add 100 µl of DMSO to one vial of Zombie Aqua™ dye and mix until fully dissolved
  3. Wash cells with PBS buffer (no Tris buffer and protein free).
  4. Dilute Zombie Aqua™ dye at 1:100-1000 in PBS. Resuspend 1-10 x 106 cells in diluted 100 µl Zombie Aqua™ solution. To minimize background staining of live cells, titrate the amount of dye and/or number of cells per 100 µl for optimal performance. Different cell types can have a wide degree of variability in staining based on cell size and degree of cell death.

    Note: Don’t use Tris buffer as a diluent and be sure that the PBS does not contain any other protein like BSA or FBS.
    Note: The amount of dye used can also influence the ability to detect apoptotic as well as live and dead cells.

  5. Incubate the cells at room temperature, in the dark, for 15-30 minutes.
  6. Wash one time with 2 ml BioLegend’s Cell Staining Buffer (Cat. No. 420201) or equivalent buffer containing serum or BSA.
  7. Continue performing antibody staining procedure as desired.
  8. Cells can be fixed with paraformaldehyde or methanol prior to permeabilization or can be analyzed without fixation.

 

No-wash Sequential Staining Protocol:

  1. Wash cells with PBS buffer (no Tris buffer and protein free).
  2. For reconstitution, pre-warm the kit to room temperature; add 100 µl of DMSO to one vial of Zombie Aqua™ dye and mix until fully  dissolved
  3. Determine the total µl volume of antibody cocktail previously titrated and optimized for the assay that will be added to each vial/well of cells based on a final volume of 100 µl. Subtract that antibody volume from the 100 µl total staining volume intended for the assay. In the remaining volume, dilute Zombie Aqua™ dye at 1:100-1000 in PBS as determined by prior optimization at that volume. For example, if you are adding 20 µl of antibody cocktail for a 100 µl total staining volume, use 80 µl of Zombie Aqua™ solution. Resuspend 1-10 x 106 cells in the appropriate volume of Zombie Aqua™ solution. Different cell types can have a wide degree of variability in staining based on cell size and degree of cell death.

    Note: Don’t use Tris buffer as a diluent and be sure that the PBS does not contain any other protein like BSA or FBS.
    Note: The amount of dye used can also influence the ability to detect apoptotic as well as live and dead cells.

  4. Incubate for 10-15 minutes at RT, protected from light. Without washing the cells, add the cell surface antibody cocktail and incubate for another 15-20 minutes.
  5. Add 1-2 mL Cell Staining Buffer (Cat. No. 420201) or equivalent buffer containing BSA or serum. Centrifuge to pellet.
  6. Continue with normal fixation and permeabilization procedure. If planning to skip fixation and analyze cells live, complete an additional wash step to minimize any unnecessary background of the live cells.


Notes: If the cell type in use cannot tolerate a protein-free environment, then titrate the Zombie Aqua™ dye in the presence of the same amount of BSA/serum as will be present in the antibody staining procedure. A higher amount of Zombie Aqua™ may be required since the BSA/serum will react with and bind up some proportion of the Zombie Aqua™.

Zombie Aqua™ dye is excited by the violet laser and has a maximum emission of 516 nm. If using in a multi-color panel design, filter optimization may be required depending on other fluorophores used. Zombie Aqua™ dye has similar emission to Brilliant Violet 510™.

Additional Product Notes

View more applications data using this product to validate Veri-Cells™ lyophilized control cells and to study dendritic cell subsets.

Application References

(PubMed link indicates BioLegend citation)
  1. Vom Berg J, et al. 2013. J Exp Med. 210:2803. PubMed
  2. Radovanovic I, et al. 2014. J Immunol. 193:1290. PubMed
  3. Price PJ, et al. 2014. J Virol. 88:10840. PubMed
  4. Schmid MA, et al. 2014. PLoS Pathog. 10:1004541. PubMed
  5. Cohen SB, et al. 2015. J Immunol. 194:210. PubMed
  6. Li J, et al. 2015. Cancer Res. 75:508. PubMed
  7. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  8. Michelet X, et al. 2015. J Immunol. 194:2079. PubMed
  9. Tzeng A, et al. 2015. PNAS. 112:3320. PubMed
  10. Peres AG, et al. 2015. Infect Immun. 83:1587. PubMed
  11. Hansmann L, et al. 2015. Cancer Immunol Res. 3:650. PubMed
Product Citations
  1. Berg J, et al. 2013. J Exp Med. 210:2803. PubMed
  2. Radovanovic I, et al. 2014. J Immunol. 193:1290. PubMed
  3. Price P, et al. 2014. J Virol. 88:10840. PubMed
  4. Schmid M, Harris E 2014. PLoS Pathog. 10:1004541. PubMed
  5. Cohen S, et al. 2015. J Immunol. 194:210. PubMed
  6. Li J, et al. 2015. Cancer Res. 75:508. PubMed
  7. Price P, et al. 2015. J Immunol. 194:1164. PubMed
  8. Michelet X, et al. 2015. J Immunol. 194:2079. PubMed
  9. Tzeng A, et al. 2015. Proc Natl Acad Sci U S A. 112:3320. PubMed
  10. Peres A, et al. 2015. Infect Immun . 83:1587. PubMed
  11. Hansmann L, et al. 2015. Cancer Immunol Res. 3:650. PubMed
  12. Fujii H, et al. 2015. PLoS One. 10: 0133216. PubMed
  13. Hatfield J, Brown M 2015. Cell Immunol. . PubMed
  14. Schmitt N, et al. 2015. Mol Cancer Ther. 14: 2103-2111. PubMed
  15. Denkers S 2015. J Immunol. 195: 2754-2762. PubMed
  16. Carpenter S, et al. 2016. PLoS Pathog. 12: 1005380. PubMed
  17. Krogmann A, et al. 2016. PLoS One. 11: 0146326. PubMed
  18. Cunningham C, et al. 2016. PLoS Pathog. 12: 1005356. PubMed
  19. Yang Y, et al. 2016. Nucleic Acids Res. 44: 4174 - 4188. PubMed
  20. Martini E, et al. 2016. Cell Rep. 14:1062-1073. PubMed
  21. Lim X, et al. 2016. Proc Natl Acad Sci U S A. 113: 1498 - 1505. PubMed
  22. Garcia-Bates T, et al. 2016. J Immunol. 196: 2870 - 2878. PubMed
  23. Concha-Benavente F, et al. 2016. Cancer Res . 76: 1031 - 1043. PubMed
  24. Larmonier C, et al. 2016. J Biol Chem. 291: 8918-8930. PubMed
  25. Crisci E, et al. 2016. J Virol. 90: 4939 - 4950. PubMed
  26. Coria L, et al. 2016. J Immunol. 196: 4014 - 4029. PubMed
  27. Contreras F, et al. 2016. J Immunol. 196: 4143 - 4149. PubMed
  28. Chattopadhyay A, et al. 2016. J Lipid Res. 57: 832 - 847. PubMed
  29. Farooq F, et al. 2016. Sci Rep. 6:27944. PubMed
  30. Schmid M, et al. 2016. PLoS One. 12: 1005676. PubMed
  31. Johns S, et al. 2016. Circ Res . 119: 210 - 221. PubMed
  32. Yamaguchi M, et al. 2016. J Leukoc Biol. 100: 131 - 141. PubMed
  33. Comte D, et al. 2016. Proc Natl Acad Sci U S A. 113: 9321 - 9326. PubMed
  34. Bittner-Eddy P, et al. 2016. J Immunol. 197: 1435 - 1446. PubMed
  35. Leong Y, et al. 2016. Nat Immunol. 17:1187-1196. PubMed
  36. McGuire V, et al. 2016. Sci Rep. 6:31159. PubMed
  37. Yoshida N, et al. 2016. Nat Commun. 7: 12993. PubMed
  38. Davidson S, et al. 2016. EMBO Mol Med. 8: 1099 - 1112. PubMed
  39. Krämer B, et al. 2016. PLoS One. 11: 0162068. PubMed
  40. LM S, et al. 2016. Cell Rep. 16(12): 3286-96. PubMed
  41. Morikawa M, et al. 2016. PLoS One. 11:e0163607. PubMed
  42. Vidy A, et al. 2016. PLoS One. 11:e0165361. PubMed
  43. Torre S, et al. 2016. Nat Immunol. 10.1038/ni.3581. PubMed
  44. Gouwy M, et al. 2016. PLoS One. 11:e0166006. PubMed
  45. Amberg N, et al. 2016. J Invest Dermatol. 136:2140-2149. PubMed
  46. Fang V, et al. 2016. Nat Immunol. 18:15-25. PubMed
  47. Sebina I, et al. 2016. PLoS Pathog. 12:e1005999. PubMed
  48. Swee L, et al. 2016. Open Bio. 6: 160293. PubMed
  49. Andriessen E, et al. 2016. EMBO Mol Med. 8(12):1366-1379. PubMed
  50. Weiss G, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.104. PubMed
  51. Ohs I, et al. 2016. Nat Commun. 7:13708. PubMed
  52. Clement M, et al. 2016. PLoS Pathog. 12:e1006050. PubMed
  53. Alberts-Grill N, et al. 2016. J Immunol. 197(12):4651-4662. PubMed
  54. Ryan P, et al. 2016. Proc Natl Acad Sci U S A. 113(50):14378-14383. PubMed
  55. OlguÍn-Alor R, et al. 2016. PLoS One. 11:e0167813. PubMed
  56. Ju X, et al. 2016. J Immunol. 197(12):4613-4625. PubMed
  57. Dutzan N, et al. 2017. Immunity. 46(1):133-147. PubMed
  58. Antsiferova M, et al. 2017. EMBO Mol Med. 9(1):27-45. PubMed
  59. Peter Morawski, Chen-Feng Qi, Silvia Boll 2017. Sci Rep. 7:40838. PubMed
  60. Yoder A, et al. 2017. PLoS Pathog. 13(2):e1006226. PubMed
  61. Neidleman J, et al. 2017. PLoS Pathog. 13(2):e1006163. PubMed
  62. Brugat T, et al. 2017. Nat Microbiol. 2:16276. PubMed
  63. Bussières-Marmen S, et al. 2017. Cell Mol Immunol. 10.1038/cmi.2016.72. PubMed
  64. Davey M, et al. 2017. Nat Commun. 10.1038/ncomms14760. PubMed
  65. Nuccitelli R, et al. 2017. J Immunother Cancer . 10.1186/s40425-017-0234-5. PubMed
  66. Rechtien A, et al. 2017. Cell Rep. 10.1016/j.celrep.2017.08.023. PubMed
  67. Martrus G, et al. 2017. PLoS One.. 10.1371/journal.pone.0182532. PubMed
  68. Kallert S, et al. 2017. Nature Communications. 10.1038/ncomms15327. PubMed
  69. Schuldt N, et al. 2017. The Journal of Immunology. 10.4049/jimmunol.1700406. PubMed
  70. Teng Y, et al. 2017. J Hematol Oncol. 10.1186/s13045-017-0485-0. PubMed
  71. Dai H, et al. 2017. J Immunol. 10.4049/jimmunol.1700418. PubMed
  72. Gálvez-Cancino F, et al. 2017. Vaccine. 10.1016/j.vaccine.2017.06.041. PubMed
  73. Pardo E, et al. 2017. PLoS One. 12(6):e0177472. PubMed
  74. Ceholski D, et al. 2017. Stem Cell Res. 10.1016/j.scr.2017.06.015. PubMed
  75. Metzemaekers M, et al. 2017. Int J Mol Sci. 10.3390/ijms18071513. PubMed
  76. Collin R, et al. 2017. J Immunol. 10.4049/jimmunol.1600789. PubMed
  77. Jeevan-Raj B, et al. 2017. Cell Rep. 10.1016/j.celrep.2017.06.071. PubMed
  78. Tien S, et al. 2017. PLoS One. 10.1371/journal.pone.0181338. PubMed
  79. Joshi N and Werner S. 2017. PLoS One. 10.1371/journal.pone.0187162. PubMed
  80. Parameswaran P, et al. 2017. Cell Host Microbe. 10.1016/j.chom.2017.08.003. PubMed
  81. Wright A, et al. 2017. J Allergy Clin Immunol. . 10.1016/j.jaci.2017.04.025. PubMed
  82. Madsen D, et al. 2017. Cell Rep.. 10.1016/j.celrep.2017.12.011. PubMed
  83. Kaczanowska S, et al. 2017. Cancer Res. . 10.1158/0008-5472.CAN-17-0653. PubMed
  84. Bailey S, et al. 2017. Nat Commun.. 10.1038/s41467-017-01867-9. PubMed
  85. Rhys HI, et al. 2018. EBioMedicine. 29:60. PubMed
  86. Chattopadhyay A, et al. 2018. Sci Rep. 8:9032. PubMed
  87. Kimura K, et al. 2018. Nat Commun. 9:17. PubMed
  88. Gálvez-Cancino F, et al. 2018. Oncoimmunology. 7:e1442163. PubMed
  89. Böttcher M, et al. 2018. Oncoimmunology. 7:e1445454. PubMed
  90. Contijoch EJ, et al. 2019. Elife. 8:. PubMed
  91. Zwick M, et al. 2019. Front Immunol. 10:222. PubMed
  92. Yuan C, et al. 2018. iScience. 11:13. PubMed
  93. Fragniere AMC, et al. 2019. Sci Rep. 9:2288. PubMed
  94. Tron AE, et al. 2018. Nat Commun. 9:5341. PubMed
  95. Becker JR, et al. 2018. Nat Commun. 9:5406. PubMed
  96. Ogrinc Wagner A, et al. 2019. PLoS One. 14:e0210998. PubMed
  97. Wilmore JR, et al. 2018. Cell Host Microbe. 23:302. PubMed
  98. Wu J, et al. 2017. Immunity. 47:1114. PubMed
  99. Louveau A, et al. 2018. Curr Protoc Immunol. 121:1. PubMed
  100. Dawson NA, et al. 2019. JCI Insight. 4:6. PubMed
  101. Freire DM, et al. 2019. Mol Cell. 73:1282. PubMed
  102. Vigeland CL, et al. 2019. Physiol Rep. 7:e14019. PubMed
  103. Padhye A, et al. 2019. Sci Rep. 9:4819. PubMed
  104. Hartsough EJ, et al. 2019. Cell Death Dis. 10:281. PubMed
  105. Grozio A, et al. 2019. Nat Metab. 1:47. PubMed
  106. Ramsey HE, et al. 2018. Cancer Discov. 8:1566. PubMed
  107. Barry KC, et al. 2018. Nat Med. 24:1178. PubMed
  108. Farsakoglu Y, et al. 2019. Cell Rep. 26:2307. PubMed
  109. Tan L, et al. 2019. Cell Rep. 27:3657. PubMed
  110. Suan D, et al. 2017. Immunity. 47:1142. PubMed
  111. Engelbertsen D, et al. 2019. Sci Rep. 9:10608. PubMed
  112. Meehan S, et al. 2019. Commun Biol. 2:229. PubMed
  113. Botuyan MV, et al. 2018. Nat Struct Mol Biol. 25:591. PubMed
  114. Britton GJ, et al. 2019. Immunity. 50:212. PubMed
Publication Library

Antigen Details

Biology Area
Apoptosis/Tumor Suppressors/Cell Death, Cell Biology, Neuroscience
Gene ID
NA

Related FAQs

Can I use methanol/ethanol for fixation after using a Zombie dye?

Yes, most fixation reagents are fine to be used with Zombie dyes. However, it should be noted that Zombie dyes can still be sensitive to reactive oxygen species. Light exposure or reagents with hydrogen peroxide can lead to free radical formation, affecting fluorescence.

Can I use the UV laser to stimulate Zombie Aqua™? If so, can I then use it in conjunction with BV510™?

While we typically do not test Zombie Aqua™ with the UV laser, its excitation peak suggests it is effectively excited at 355 nm. However, we would not recommend using BV510™ off the violet laser and Zombie Aqua™ off the UV laser at the same time. Due to cross-beam excitation of BV510™ by the UV laser and the violet excitation of Zombie Aqua™, this would lead to significantly increased background and excessive compensation requirements.

Can I use your Zombie dyes for microscopy application?

Zombie dyes that have been tested for microscopy applications in-house will display data on the product webpage. It should be noted that Zombie may not work for dead cell discrimination in every microscopy application, as a complicated point will be to determine the level of Zombie signal that constitutes a dead cell. Another difficulty may be finding the proper plane for microscopy in order to observe the dead cells.

Can I use Zombie and Annexin V to detect apoptotic cells?

Yes, Zombie can be used with Annexin V to discriminate live, apoptotic, and dead cells. Cells double positive for both Zombie and Annexin V are dead, while Zombie-dim/Annexin V-positive cells are apoptotic. Live cells will be Zombie-low and Annexin V-negative. The advantage to Zombie over PI and 7-AAD is that you can now fix and/or permeabilize the cells to stain for cell surface and intracellular antigens.

Can I use Zombie with cells suspension containing serum?
Serum is full of proteins which will sequester the dye and thereby reducing its effective concentration. The basic rule of thumb with zombie is to titrate it based on your specific condition. Titration also helps reduce the background and spillover into other channels.
Can Zombie be used to determine bacteria, yeast viability?
We have not tested in house bacterial or yeast viability using Zombie dyes. It is not clear whether the difference between surface and intracellular signals will be significantly different in case of non mammalian cells.
How does the performance of your Zombie dye compare with competitors?

Zombie dyes have been tested against other leading competitors' fixable viability kits and given comparable results. We also highly recommend that you titrate down the amount of each dye used in order to best match the negative signals of your unstained sample and MFI- (mean fluorescence intensity) stained samples.

I am concerned about the spillover I am observing from the Zombie dye into its neighboring channels.
Rule of thumb with Zombie dyes is to titrate them down as much as possible to fit your application. This should potentially help with spillover. Secondly, Zombie positive events represent dead cells and are typically gated out from analysis.
Is Zombie Aqua™ an equivalent to cell labeling and tracer dyes such as CellTrace™ Violet and CFSE?
Zombie Aqua™ is not a direct equivalent to such dyes because their mechanism of action and scope of application are entirely different.
Why can't I fix my cells prior to using Zombie?

The fixation process can contort and alter the membrane of cells, effectively rendering them as dead. Since the ability of Zombie to stain dead cells is correlated with cell permeability, your results may no longer be a valid representation of dead versus live cells.

Go To Top Version: 6    Revision Date: 05.30.2019

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

Login / Register
Forgot your password? Reset password?
Create an Account